Table 3.
Univariate and multivariate analysis of clinicopathological features for progression-free survival of EOC patients
| Parameters | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| Age: ≥60 years vs <60 years | 0.759 | 0.527 −1.094 |
0.140 | |||
| CA125: <500 U/mL vs ≥500 U/mL | 1.103 | 0.762 −1.597 |
0.603 | |||
| Cancer type: Type I vs Type II | 2.054 | 1.418 −2.974 |
<0.001 | 1.721 | 1.175 −2.520 |
0.005 |
| Ascites: <100 mL vs ≥100 mL | 1.371 | 0.944 −1.990 |
0.097 | |||
| FIGO stage: III/IV vs I/II | 1.911 | 1.199 −3.046 |
0.006 | 1.659 | 1.031 −2.670 |
0.037 |
| SNHG15: high vs low | 1.134 | 1.072 −1.200 |
,0.001 | 1.120 | 1.056 −1.189 |
<0.001 |
Abbreviations: EOC, epithelial ovarian cancer; FIGO, International Federation of Gynaecology and Obstetrics.